703 filings
Page 10 of 36
8-K
751e12vhh0u447w je1p
28 Apr 17
CytRx Corporation Announces Proposed Public Offering of Common Stock
12:00am
424B2
nj3c4q3ns j1zhd
27 Apr 17
Prospectus for primary offering
12:00am
EFFECT
nh5nmp13jsx41y5m
21 Apr 17
Notice of effectiveness
12:00am
UPLOAD
rsvoj5pt5cw
19 Apr 17
Letter from SEC
12:00am
8-K
l1bw6bi63s4o8zk8
19 Apr 17
CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue Sarcomas
12:00am
CORRESP
f2djcg20 c0wkjivhu
19 Apr 17
Correspondence with SEC
12:00am
424B3
yjmgn 86i
3 Apr 17
Prospectus supplement
12:00am
424B3
geh5rfzwa
3 Apr 17
Prospectus supplement
12:00am
EFFECT
c43y0vfa7dkotpze
30 Mar 17
Notice of effectiveness
12:00am
EFFECT
8uo8ka1qk9 753k
27 Mar 17
Notice of effectiveness
12:00am
CORRESP
vnvz4b2
23 Mar 17
Correspondence with SEC
12:00am
POS AM
lbg35gfhfaypgnphph
20 Mar 17
Prospectus update (post-effective amendment)
12:00am
EFFECT
jwp9jc cq
17 Mar 17
Notice of effectiveness
12:00am
EFFECT
use1boapka 2tyv
17 Mar 17
Notice of effectiveness
12:00am
8-K
g4w j68u3yacp
15 Mar 17
CytRx Reports 2016 Financial Results
12:00am
8-K/A
le276d
15 Mar 17
Results of Operations and Financial Condition
12:00am
POS AM
x5axf 3dzr
14 Mar 17
Prospectus update (post-effective amendment)
12:00am